HLS in last-minute talks too prevent closure

Huntingdon Life Sciences (HLS) is in eleventh-hour talks with an unidentified US financial group to avert closure in the next 36 hours.

The American company is weighing up a cash infusion of £20m to secure the future of HLS.

HLS